Effect of immunoglobulin therapy on phagocytosis by polymorphonuclear leucocytes in whole blood of neonates

Clinical and Experimental Immunology

Volumn 107, Issue 3, 1997, Pages 435-439

  Fujiwara, T ^a   Taniuchi, S ^a   Hattori, K ^a   Kobayashi, T ^a   Kinoshita, Y ^a   Kobayashi, Y ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Hydrogen peroxide; Immunoglobulin therapy; Neonates; Phagocytosis; Polymorphonuclear leucocytes; Production

Indexed keywords

HYDROGEN PEROXIDE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; INTRAVENOUS DRUG ADMINISTRATION; NEUTROPHIL; NEWBORN; PHAGOCYTOSIS; PRIORITY JOURNAL;

EID: 0031041129     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.d01-957.x     Document Type: Article

References (35)

1. Shaio M-F, Yang KD, Bohnsack JF, Hill HR. Effect of immune globulin intravenous on opsonization of bacteria by classic and alternative complement pathways in premature serum. Pediatr Res 1989; 25: 634-40.
2. Sidiropoulos D, Herrmann LJ Jr, Morell A, von Muralt G, Barandun S. Transplacental passage of intravenous immunoglobulin in the last trimester of pregnancy. J Pediatr 1986; 109:505-8.
3. Hobbs JR, Davis JA. Serum γ G-globulin levels and gestational age in premature babies. Lancet 1967; 1:757-9.
4. Hill HR. Biochemical, structural, and functional abnormalities of polymorphonuclear leucocytes in the neonate. Pediatr Res 1987; 22: 375-82.
5. Wilson CB. Immunologic basis for increased susceptibility of the neonate to infection. J Pediatr 1986; 108:1-12.
6. Forman ML, Stiehm ER. Impaired opsonic activity but normal phagocytosis in low-birth-weight infants. N Engl J Med 1969; 281: 926-31.
7. Miller ME. Phagocytosis in the newborn infant: humoral and cellular factors. J Pediatr 1969; 74:255-9.
8. Kobayashi Y, Usui T. Opsonic activity of cord serum - an evaluation based on determination of oxygen consumption by leucocytes. Pediatr Res 1982; 16:243-6.
9. Bortolussi R, Fischer GW. Opsonic and protective activity of immunoglobulin, modified immunoglobulin, and serum against neonatal Escherichia coli K1 infection. Pediatr Res 1986; 20:175-8.
10. Santos JI, Shigeoka AO, Rote NS, Hill HR. Protective efficacy of a modified immune serum globulin in experimental group B streptococcal infection. J Pediatr 1981; 99:873-9.
11. Nolte MT, Pirofsky B, Gerritz GA, Golding B. Intravenous immunoglobulin therapy for antibody deficiency. Clin Exp Immunol 1979; 36:237-43.
12. Roifman CM, Levison H, Gelfand EW. High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease. Lancet 1987; 1:1075-7.
13. Clapp DW, Kliegman RM, Baley JE, Shenker N, Kyllonen K, Fanaroff AA, Berger M. Use of intravenously administered immune globulin to prevent nosocomial sepsis in low birth weight infants: report of a pilot study. J Pediatr 1989; 115:973-8.
14. Chirico G, Rondini G, Plebani A, Chiara A, Massa M, Ugazio AG. Intravenous gammaglobulin therapy for prophylaxis of infection in high-risk neonates. J Pediatr 1987; 110:437-42.
15. Baker CJ, Melish ME, Hall RT, Casto DT, Vasan U, Givner LB and The Multicenter Group for The Study of Immune Globulin in Neonates. Intravenous immune globulin for the prevention of nosocomial infection in low-birth-weight neonates. N Engl J Med 1992; 327:213-9.
16. Stabile A, Sopo SM, Romanelli V, Pastore M, Pesaresi MA. Intravenous immunoglobulin for prophylaxis of neonatal sepsis in premature infants. Arch Dis Child 1988; 63:441-3.
17. Magny JF, Bremard-Oury C, Brault D, Menguy C, Voyer M, Landais P, Dehan M, Gabilan JC. Intravenous immunoglobulin therapy for prevention of infection in high-risk premature infants; report of a multicenter, double-blind study. Pediatrics 1991; 88:437-43.
18. Kinney J, Mundorf L, Gleason C et al. Efficacy and pharmacokinetics of intravenous immune globulin administration to high-risk neonates. Am J Dis Child 1991; 145:1233-8.
19. von Muralt G, Sidiropoulos D. Experience with intravenous immunoglobulin treatment in neonates and pregnant women. Vox Sang 1986; 51:22-29.
20. Haque KN, Zaidi MH, Bahakim H. IgM-enriched intravenous immunoglobulin therapy in neonatal sepsis. Am J Dis Child 1988; 142:1293-6.
21. Friedman CA, Wender DF, Temple DM, Rawson JE. Intravenous gamma globulin as adjunct therapy for severe group B streptococcal disease in the newborn. Am J Perinatol 1990; 7:1-4.
22. Weisman LE, Stoll BJ, Kueser TJ et al. Intravenous immune globulin therapy for early-onset sepsis in premature neonates. J Pediatr 1992; 121:434-43.
23. Christensen RD, Brown MS, Hall DC, Lassiter HA, Hill HR. Effect on neutrophil kinetics and serum opsonic capacity of intravenous administration of immune globulin to neonates with clinical signs of early-onset sepsis. J Pediatr 1991; 118:606-14.
24. Weisman LE, Lorenzetti PM. High intravenous doses of human immune globulin suppress neonatal group B streptococcal immunity in rats. J Pediatr 1989; 115:445-50.
25. Kim KS. High-dose intravenous immune globulin impairs antibacterial activity of antibiotics. J Allergy Clin Immunol 1989; 84:579-88.
26. Sato K, Hara T, Kondo I, Miyazaki S. High-dose intravenous gammaglobulin therapy for neonatal immune haemolytic jaundice due to blood group incompatibility. Acta Paediatr Scand 1991; 80:163-6.
27. Hasui M, Hirabayashi Y, Kobayashi Y. Simultaneous measurement by flow cytometry of phagocytosis and hydrogen peroxide production of neutrophils in whole blood. J Immunol Methods 1989; 117: 53-58.
28. Horwitz MA. Phagocytosis of microorganisms. Rev Infect Dis 1982; 4:104-23.
29. Babior BM. The respiratory burst of phagocytes. J Clin Invest 1984; 73:599-601.
30. Fehr J, Hofmann V, Kappeler U. Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin. N Engl J Med 1982; 306:1254-8.
31. Atrah HI, Davidson RJL. Mechanism of action of intravenous immunoglobulin in immune-mediated cytopenias. J Clin Pathol 1988; 41:1249-55.
32. DeChatelet LR, Shirley PS, Johnston RB Jr. Effect of phorbol myristate acetate on the oxidative metabolism of human polymorphonuclear leucocytes. Blood 1976; 47:545-54.
33. Eisenfeld L, Krause PJ, Herson VC, Block C, Schick JB, Maderazo E. Enhancement of neonatal neutrophil motility (chemotaxis) with adult fresh frozen plasma. Am J Perinatol 1992; 9:5-8.
34. Durandy A, Fischer A, Griscelli C. Dysfunctions of pokeweed mitogen-stimulated T and B lymphocyte responses induced by gammaglobulin therapy. J Clin Invest 1981; 67:867-77.
35. Hashimoto F, Sakiyama Y, Matsumoto S. The suppressive effect of gammaglobulin preparations on in vitro pokeweed mitogen-induced immunoglobulin production. Clin Exp Immunol 1986; 65:409-15.